Brief: Sedana Medical Reports Topline Results From Phase 3 Study
May 17 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL REPORTS TOPLINE RESULTS FROM PHASE 3
PAEDIATRIC
ISOCOMFORT STUDY
* PRIMARY ENDPOINT OF ITS PHASE 3 ISOCOMFORT STUDY WAS MET
IN FULL
ANALYSIS SET, BUT WAS NOT MET IN PER-PROTOCOL ANALYSIS
* COMPLETION OF TRIAL EXTENDS COMPANY'S DATA EXCLUSIVITY OF
ADULT
INDICATION TO 2031
Source text for Eikon: ID:nWkr7wgcTB
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln